retatrutide weight loss phase 2 trial results Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Difference between tirzepatide and retatrutide:

HFD-induces GSH deficiency and epigenetically alters VD-biosynthesis pathway genes

Astrocyte depletion impairs redox homeostasis and triggers neuronal loss in the adult CNS

B12 injections can significantly boost energy levels, improve mental clarity, enhance sleep patterns, and support red blood cell production, contributing to overall wellness

The difference between a potent, effective dose and a degraded waste of money often comes down to a single number printed on the label, a number that most people either ignore or misunderstand entirely

The effect of low-carbohydrate diet on glycemic control in patients with type 2 diabetes mellitus